Roivant Sciences Ltd
ROIV
Market Cap$8.42B
Close$
$-1.70
115.2% downside
Current Fair Value
115.2% downsideOvervalued by 115.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $8.42 Billion |
|---|---|
| Enterprise Value | $6.53 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $5.55 |
| Beta | 1.25 |
| Outstanding Shares | 735,816,536 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 1.77 |
|---|---|
| PEG | -1.83 |
| Price to Sales | - |
| Price to Book Ratio | 1.6 |
| Enterprise Value to Revenue | 66.9 |
| Enterprise Value to EBIT | -6.91 |
| Enterprise Value to Net Income | -56 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data